Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Whitfield's Solution and Zinc Oxide Nanoparticles for Fungal Foot Infection
NCT05901961Phase 4Completed
- Sponsor
- Mahidol University
- Start
- Jun 2023
- Primary completion
- Sep 2023
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of Whitfield solution and zinc oxide nanoparticles in tinea pedis (3 arms), sponsored by Mahidol University. Primary endpoint: Efficacy in treating fungal foot infection at 8 weeks. Started Jun 2023; status: completed.
02
Drugs
Whitfield solutionzinc oxide nanoparticles
03
Conditions
tinea pedis
Beyond the preview
Go deeper on NCT05901961.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05901961.